ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer

Activation of cancer stem cell signaling is central to acquired resistance to therapy in esophageal cancer (EC). ABT-263, a potent Bcl-2 family inhibitor, is active against many tumor types. However, effect of ABT-263 on EC cells and their resistant counterparts are unknown. Here we report that ABT-...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Chen, Qiongrong, Song, Shumei, Wei, Shaozhong, Liu, Bin, Honjo, Soichiro, Scott, Ailing, Jin, Jiankang, Ma, Lang, Zhu, Haitao, Skinner, Heath D., Johnson, Randy L., Ajani, Jaffer A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2015
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694873/
https://ncbi.nlm.nih.gov/pubmed/26317542
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk